Timothy Kopatich photo

BIOTECH

Timothy Kopatich

CEO,

Cellebration Life Sciences, Inc.

  • CEO of Cellebration Life Sciences, Inc.
  • 25 Years of Experience in Corporate Finance and Real Estate Assets
  • 7 Years Experience in the Biotech Sector

About Timothy

Timothy Kopatich is the CEO of Cellebration Life Sciences, Inc. mission is to offer and administer stem-cell based therapies which are highly specialized to treat specific degenerative conditions and directly target the area of concern in rejuvenation therapies. Mr. Kopatich has over 25 years of experience in the field of corporate finance and managing real estate assets. He has been involved in the Biotech sector for over seven years and has successfully opened multiple wellness centers.

Timothy's Videos

In a dynamic intersection of science and finance, leaders Tim Kopatich, CEO of Cellebration Life Sciences, and Sydney Armani, CEO of Fintech World, are pioneering advancements in the realm of stem cell treatment and investment. Their collaborative efforts signify a promising frontier where cutting-edge medical breakthroughs meet strategic financial innovation. This note delves into the exciting landscape they navigate, showcasing the potential impact on healthcare and the investment landscape. 

The world's population is getting increasingly older and sicker. To meet the market's need in this growing healthcare crisis, we have established a fund to catalyze the most promising stem cell research and combat some of the most debilitating and costly diseases that will affect each of us today and into the future.

Live Now

MoneyShow/TradersEXPO Las Vegas

February 21 - 23, 2024